Key result
Haloperidol-propofol reduces propofol consumption and respiratory depression versus midazolam-propofol.
Why the study?
The comparative effects of haloperidol-propofol versus midazolam-propofol infusion on propofol consumption and respiratory and hemodynamic profiles in agitated ICU patients after CABG were unclear.
Does haloperidol-propofol infusion reduce propofol consumption and improve respiratory profile compared to midazolam-propofol infusion in agitated ICU patients after CABG?
RCT (n=60)
Double-blind
Randomly divided into two groups
Does haloperidol-propofol infusion reduce propofol consumption and improve respiratory profile compared to midazolam-propofol infusion in agitated ICU patients after CABG?
p-value: p=0.001
In agitated patients after CABG, a haloperidol-propofol combination reduces propofol requirements and the incidence of respiratory depression compared to a midazolam-propofol combination.
Supports haloperidol-propofol sedation in post-CABG agitation; extends RCT evidence for adjunctive antipsychotics in cardiac ICU.
Combinations of hypnotics with or without opiates are commonly used in agitated patients. We hypothesized that combination of haloperidol-propofol in comparison with midazolam-propofol would lower consumption of propofol and lead to better hemodynamic and respiratory profile during sedation of agitated patients. Among 108 patients admitted in our ICU, 60 patients were agitated according to Ramsay Sedation Score (RSS) and randomly divided into two groups. Morphine sulfate (0.05 mg/kg) was administered to all patients for relief of postoperative pain. In one group, sedative infusion was started with 1 mg/h of haloperidol plus 25 μg/kg/min of propofol after bolus injection of 2 mg haloperidol. In the other group, midazolam1 mg/h and propofol 25 μg/kg/min were infused after a bolus injection of 2 mg midazolam. Propofol infusion was adjusted to keep bi-spectral index between 61-80 and the RSS between 3-5. Hourly propofol consumption was recorded during 24 h of sedation and compared statistically. We also compared SpO 2 , arterial blood gas variables, hemodynamic parameters and episodes of respiratory depression (SpO 2 ≤85%) requiring respiratory support between the groups. Haloperidol, when added to propofol infusion, decreased its consumption at all the measured times (P = 0.001). There was no significant difference in hemodynamic variables between two groups, but the episodes of respiratory depression was significantly higher in propofol-midazolam group (P = 0.02). We conclude that haloperidol-propofol infusion decreases propofol requirements in the agitated patients. Besides, this combination showed a better profile in terms of occurrence of respiratory depression.
No takes yet. Share an insight, caveat, or question.
Khajavi et al. (2012) conducted an RCT in Agitation after coronary artery bypass graft surgery (n=60). Haloperidol-propofol infusion vs. Midazolam-propofol infusion (bolus injection of 2 mg midazolam followed by 1 mg/h midazolam and 25 μg/kg/min propofol) was evaluated on Hourly propofol consumption during 24 h of sedation (p=0.001). Haloperidol-propofol infusion significantly decreased propofol consumption (P=0.001) and resulted in fewer episodes of respiratory depression (P=0.02) compared to midazolam-propofol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: